ARCA biopharma, Inc. Skyrocketed
Fri, Sep 06, 2024 at 07:33 PM
ARCA biopharma, Inc. (ABIO:NASDAQ) soared at $28.8, a gain of 1052%. On Fri, Sep 06, 2024, ABIO:NASDAQ touched a New 2-Week Intraday Low of $2.25. The stock appeared on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Fri, Aug 23, 2024, the stock recorded 22.22% Up Days and 80.00% Green Days
About ARCA biopharma, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- BloomZ Inc. (BLMZ:NASDAQ), 119.06%
- Ryde Group Ltd. Class A (RYDE:NYSEMKT), 42.75%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 39.41%
- Solarmax Technology Inc. (SMXT:NASDAQ), 39.25%
- Beneficient (BENF:NASDAQ), 36.67%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 35.71%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 31.1%
- Argan, Inc. (AGX:NYSE), 26.04%
- Primega Group Holdings Limited (PGHL:NASDAQ), 25.67%